MONTECET
Montelukast Sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.
Levocetirizine HCL, is an orally active H1-receptor antagonist.
40 mg Lyophilized Powder for Injection (I.V)
PROTON PUMP INHIBITOR
FORMULATION:
Each vial contains:
Omeprazole (as sodium) ………………………………………. 40 mg
DOSAGE AND ADMINISTRATION:
Adults Only
Treatment in patients where oral therapy is inappropriate e.g. in severely ill patients with wither reflux esophagitis, duodenal ulcer or gastric ulcer: Omeprazole given as an intravenous infusion once daily is recommended for up to 5 days. Prophylaxis of acid aspiration. Omeprazole 40 mg given as an intravenous infusion to be completed one hour before the surgery.
Administration
Omeprazole Powder for infusion is for intravenous administration only be dissolved in either 100 ml Normal Saline for Infusion or 100 ml 5% Dextrose for infusion. No other solutions for I.V infusion should be used. After reconstitution from a microbiological point of view, use immediately (i.e within hours) and any unused portion should be discarded. The duration of administration should be 20-30 minutes.
Use in elderly: Dosage adjustment is not necessary.
Use in children:There is limited experience of use in children. Impaired renal function: Dosage adjustment is not required in patients with impaired renal function.
Preparation:
1. With a syringe draw approximately 5ml of infusion solution from the infusion bottle or bag.
2. Add infusion solution to the vial with the freeze-dried Omeprazole, mixed thoroughly making sure all Omeprazole is dissolved.
3.Draw the Omeprazole solution back into the syringe.
4.Transfer the solution in the infusion bottle or bag.
5.Repeat 1-4 to make sure all Omeprazole is transferred from the vial into the infusion bottle or bag.
Omeprazole is used to treat conditions where reduction in acid secretion is required for proper healing, including stomach and intestinal ulcers (gastric and duodenal ulcers), the prevention and treatment of ulcers associated with medications known as NSAIDs, Reflux Esophagitis, Zollinger-Ellison syndrome, Heartburn, and Gastroesophageal Reflux Disease (GERD).
FDA Registration Number: DRP-8396-04
Manufacturer: CSPC Pharmaceutical (Shijiazhuang) Co., Ltd
© 2019, Quadgen Pharmaceutical. All rights reserved. Developed by JG DevArt.